世界の間欠性跛行市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Intermittent Claudication Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5216 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、間欠性跛行の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、血行再建術）、用途別市場規模（病院、クリニック、在宅医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・間欠性跛行の市場動向 ・企業の競争状況、市場シェア ・間欠性跛行の種類別市場規模と予測2016-2027（薬物療法、血行再建術） ・間欠性跛行の用途別市場規模と予測2016-2027（病院、クリニック、在宅医療、その他） ・間欠性跛行の北米市場規模2016-2027（アメリカ、カナダ） ・間欠性跛行の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・間欠性跛行のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・間欠性跛行の中南米市場規模2016-2027（メキシコ、ブラジル） ・間欠性跛行の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（I'ROM GROUP(DNAVEC Corporation)、Nuo Therapeutics Inc.、Kowa Company Ltd.、LTT Bio-Pharma、Pluristem Therapeutics Inc.、Nuo Therapeutics, Inc.(Aldagen, Inc.)、Genovate Biotechnology Co., Ltd.、Novartis AG、ID Pharma Co., Ltd、Helixmith Co., Ltd.、G. Pohl-Boskamp GmbH & Co. KG） ・結論

Intermittent claudication is a type of muscle pain especially in calf muscle during exercise, such as walking, and is relieved by a short period of rest due to lack of blood supply.

Market Analysis and Insights: Global Intermittent Claudication Market
The global Intermittent Claudication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intermittent Claudication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intermittent Claudication market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Intermittent Claudication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Intermittent Claudication market.

Global Intermittent Claudication Scope and Market Size
Intermittent Claudication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intermittent Claudication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
by Treatment Process
Medication Therapies
Revascularization
by Drug Type
ALD-301
DVC1-0101
K-134
LT-0101
PLX-PAD
Tirasemtiv

Segment by Application
Hospitals
Clinics
Home Healthcare
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
I’ROM GROUP(DNAVEC Corporation)
Nuo Therapeutics Inc.
Kowa Company Ltd.
LTT Bio-Pharma
Pluristem Therapeutics Inc.
Nuo Therapeutics, Inc.(Aldagen, Inc.)
Genovate Biotechnology Co., Ltd.
Novartis AG
ID Pharma Co., Ltd
Helixmith Co., Ltd.
G. Pohl-Boskamp GmbH & Co. KG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intermittent Claudication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication Therapies
1.2.3 Revascularization
1.3 Market by Application
1.3.1 Global Intermittent Claudication Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Healthcare
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Intermittent Claudication Market Perspective (2016-2027)
2.2 Intermittent Claudication Growth Trends by Regions
2.2.1 Intermittent Claudication Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Intermittent Claudication Historic Market Share by Regions (2016-2021)
2.2.3 Intermittent Claudication Forecasted Market Size by Regions (2022-2027)
2.3 Intermittent Claudication Industry Dynamic
2.3.1 Intermittent Claudication Market Trends
2.3.2 Intermittent Claudication Market Drivers
2.3.3 Intermittent Claudication Market Challenges
2.3.4 Intermittent Claudication Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Intermittent Claudication Players by Revenue
3.1.1 Global Top Intermittent Claudication Players by Revenue (2016-2021)
3.1.2 Global Intermittent Claudication Revenue Market Share by Players (2016-2021)
3.2 Global Intermittent Claudication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Intermittent Claudication Revenue
3.4 Global Intermittent Claudication Market Concentration Ratio
3.4.1 Global Intermittent Claudication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intermittent Claudication Revenue in 2020
3.5 Intermittent Claudication Key Players Head office and Area Served
3.6 Key Players Intermittent Claudication Product Solution and Service
3.7 Date of Enter into Intermittent Claudication Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Intermittent Claudication Breakdown Data by Type
4.1 Global Intermittent Claudication Historic Market Size by Type (2016-2021)
4.2 Global Intermittent Claudication Forecasted Market Size by Type (2022-2027)

5 Intermittent Claudication Breakdown Data by Application
5.1 Global Intermittent Claudication Historic Market Size by Application (2016-2021)
5.2 Global Intermittent Claudication Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Intermittent Claudication Market Size (2016-2027)
6.2 North America Intermittent Claudication Market Size by Type
6.2.1 North America Intermittent Claudication Market Size by Type (2016-2021)
6.2.2 North America Intermittent Claudication Market Size by Type (2022-2027)
6.2.3 North America Intermittent Claudication Market Size by Type (2016-2027)
6.3 North America Intermittent Claudication Market Size by Application
6.3.1 North America Intermittent Claudication Market Size by Application (2016-2021)
6.3.2 North America Intermittent Claudication Market Size by Application (2022-2027)
6.3.3 North America Intermittent Claudication Market Size by Application (2016-2027)
6.4 North America Intermittent Claudication Market Size by Country
6.4.1 North America Intermittent Claudication Market Size by Country (2016-2021)
6.4.2 North America Intermittent Claudication Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Intermittent Claudication Market Size (2016-2027)
7.2 Europe Intermittent Claudication Market Size by Type
7.2.1 Europe Intermittent Claudication Market Size by Type (2016-2021)
7.2.2 Europe Intermittent Claudication Market Size by Type (2022-2027)
7.2.3 Europe Intermittent Claudication Market Size by Type (2016-2027)
7.3 Europe Intermittent Claudication Market Size by Application
7.3.1 Europe Intermittent Claudication Market Size by Application (2016-2021)
7.3.2 Europe Intermittent Claudication Market Size by Application (2022-2027)
7.3.3 Europe Intermittent Claudication Market Size by Application (2016-2027)
7.4 Europe Intermittent Claudication Market Size by Country
7.4.1 Europe Intermittent Claudication Market Size by Country (2016-2021)
7.4.2 Europe Intermittent Claudication Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Intermittent Claudication Market Size (2016-2027)
8.2 Asia-Pacific Intermittent Claudication Market Size by Type
8.2.1 Asia-Pacific Intermittent Claudication Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Intermittent Claudication Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Intermittent Claudication Market Size by Type (2016-2027)
8.3 Asia-Pacific Intermittent Claudication Market Size by Application
8.3.1 Asia-Pacific Intermittent Claudication Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Intermittent Claudication Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Intermittent Claudication Market Size by Application (2016-2027)
8.4 Asia-Pacific Intermittent Claudication Market Size by Region
8.4.1 Asia-Pacific Intermittent Claudication Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Intermittent Claudication Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Intermittent Claudication Market Size (2016-2027)
9.2 Latin America Intermittent Claudication Market Size by Type
9.2.1 Latin America Intermittent Claudication Market Size by Type (2016-2021)
9.2.2 Latin America Intermittent Claudication Market Size by Type (2022-2027)
9.2.3 Latin America Intermittent Claudication Market Size by Type (2016-2027)
9.3 Latin America Intermittent Claudication Market Size by Application
9.3.1 Latin America Intermittent Claudication Market Size by Application (2016-2021)
9.3.2 Latin America Intermittent Claudication Market Size by Application (2022-2027)
9.3.3 Latin America Intermittent Claudication Market Size by Application (2016-2027)
9.4 Latin America Intermittent Claudication Market Size by Country
9.4.1 Latin America Intermittent Claudication Market Size by Country (2016-2021)
9.4.2 Latin America Intermittent Claudication Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Intermittent Claudication Market Size (2016-2027)
10.2 Middle East & Africa Intermittent Claudication Market Size by Type
10.2.1 Middle East & Africa Intermittent Claudication Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Intermittent Claudication Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Intermittent Claudication Market Size by Type (2016-2027)
10.3 Middle East & Africa Intermittent Claudication Market Size by Application
10.3.1 Middle East & Africa Intermittent Claudication Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Intermittent Claudication Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Intermittent Claudication Market Size by Application (2016-2027)
10.4 Middle East & Africa Intermittent Claudication Market Size by Country
10.4.1 Middle East & Africa Intermittent Claudication Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Intermittent Claudication Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 I’ROM GROUP(DNAVEC Corporation)
11.1.1 I’ROM GROUP(DNAVEC Corporation) Company Details
11.1.2 I’ROM GROUP(DNAVEC Corporation) Business Overview
11.1.3 I’ROM GROUP(DNAVEC Corporation) Intermittent Claudication Introduction
11.1.4 I’ROM GROUP(DNAVEC Corporation) Revenue in Intermittent Claudication Business (2016-2021)
11.1.5 I’ROM GROUP(DNAVEC Corporation) Recent Development
11.2 Nuo Therapeutics Inc.
11.2.1 Nuo Therapeutics Inc. Company Details
11.2.2 Nuo Therapeutics Inc. Business Overview
11.2.3 Nuo Therapeutics Inc. Intermittent Claudication Introduction
11.2.4 Nuo Therapeutics Inc. Revenue in Intermittent Claudication Business (2016-2021)
11.2.5 Nuo Therapeutics Inc. Recent Development
11.3 Kowa Company Ltd.
11.3.1 Kowa Company Ltd. Company Details
11.3.2 Kowa Company Ltd. Business Overview
11.3.3 Kowa Company Ltd. Intermittent Claudication Introduction
11.3.4 Kowa Company Ltd. Revenue in Intermittent Claudication Business (2016-2021)
11.3.5 Kowa Company Ltd. Recent Development
11.4 LTT Bio-Pharma
11.4.1 LTT Bio-Pharma Company Details
11.4.2 LTT Bio-Pharma Business Overview
11.4.3 LTT Bio-Pharma Intermittent Claudication Introduction
11.4.4 LTT Bio-Pharma Revenue in Intermittent Claudication Business (2016-2021)
11.4.5 LTT Bio-Pharma Recent Development
11.5 Pluristem Therapeutics Inc.
11.5.1 Pluristem Therapeutics Inc. Company Details
11.5.2 Pluristem Therapeutics Inc. Business Overview
11.5.3 Pluristem Therapeutics Inc. Intermittent Claudication Introduction
11.5.4 Pluristem Therapeutics Inc. Revenue in Intermittent Claudication Business (2016-2021)
11.5.5 Pluristem Therapeutics Inc. Recent Development
11.6 Nuo Therapeutics, Inc.(Aldagen, Inc.)
11.6.1 Nuo Therapeutics, Inc.(Aldagen, Inc.) Company Details
11.6.2 Nuo Therapeutics, Inc.(Aldagen, Inc.) Business Overview
11.6.3 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Introduction
11.6.4 Nuo Therapeutics, Inc.(Aldagen, Inc.) Revenue in Intermittent Claudication Business (2016-2021)
11.6.5 Nuo Therapeutics, Inc.(Aldagen, Inc.) Recent Development
11.7 Genovate Biotechnology Co., Ltd.
11.7.1 Genovate Biotechnology Co., Ltd. Company Details
11.7.2 Genovate Biotechnology Co., Ltd. Business Overview
11.7.3 Genovate Biotechnology Co., Ltd. Intermittent Claudication Introduction
11.7.4 Genovate Biotechnology Co., Ltd. Revenue in Intermittent Claudication Business (2016-2021)
11.7.5 Genovate Biotechnology Co., Ltd. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Intermittent Claudication Introduction
11.8.4 Novartis AG Revenue in Intermittent Claudication Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 ID Pharma Co., Ltd
11.9.1 ID Pharma Co., Ltd Company Details
11.9.2 ID Pharma Co., Ltd Business Overview
11.9.3 ID Pharma Co., Ltd Intermittent Claudication Introduction
11.9.4 ID Pharma Co., Ltd Revenue in Intermittent Claudication Business (2016-2021)
11.9.5 ID Pharma Co., Ltd Recent Development
11.10 Helixmith Co., Ltd.
11.10.1 Helixmith Co., Ltd. Company Details
11.10.2 Helixmith Co., Ltd. Business Overview
11.10.3 Helixmith Co., Ltd. Intermittent Claudication Introduction
11.10.4 Helixmith Co., Ltd. Revenue in Intermittent Claudication Business (2016-2021)
11.10.5 Helixmith Co., Ltd. Recent Development
11.11 G. Pohl-Boskamp GmbH & Co. KG
11.11.1 G. Pohl-Boskamp GmbH & Co. KG Company Details
11.11.2 G. Pohl-Boskamp GmbH & Co. KG Business Overview
11.11.3 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Introduction
11.11.4 G. Pohl-Boskamp GmbH & Co. KG Revenue in Intermittent Claudication Business (2016-2021)
11.11.5 G. Pohl-Boskamp GmbH & Co. KG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Intermittent Claudication Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication Therapies
Table 3. Key Players of Revascularization
Table 4. Global Intermittent Claudication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Intermittent Claudication Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Intermittent Claudication Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Intermittent Claudication Market Share by Regions (2016-2021)
Table 8. Global Intermittent Claudication Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Intermittent Claudication Market Share by Regions (2022-2027)
Table 10. Intermittent Claudication Market Trends
Table 11. Intermittent Claudication Market Drivers
Table 12. Intermittent Claudication Market Challenges
Table 13. Intermittent Claudication Market Restraints
Table 14. Global Intermittent Claudication Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Intermittent Claudication Market Share by Players (2016-2021)
Table 16. Global Top Intermittent Claudication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intermittent Claudication as of 2020)
Table 17. Ranking of Global Top Intermittent Claudication Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Intermittent Claudication Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intermittent Claudication Product Solution and Service
Table 21. Date of Enter into Intermittent Claudication Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intermittent Claudication Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Intermittent Claudication Revenue Market Share by Type (2016-2021)
Table 25. Global Intermittent Claudication Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Intermittent Claudication Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Intermittent Claudication Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Intermittent Claudication Revenue Market Share by Application (2016-2021)
Table 29. Global Intermittent Claudication Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Intermittent Claudication Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Intermittent Claudication Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Intermittent Claudication Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Intermittent Claudication Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Intermittent Claudication Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Intermittent Claudication Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Intermittent Claudication Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Intermittent Claudication Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Intermittent Claudication Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Intermittent Claudication Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Intermittent Claudication Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Intermittent Claudication Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Intermittent Claudication Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Intermittent Claudication Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Intermittent Claudication Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Intermittent Claudication Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Intermittent Claudication Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Intermittent Claudication Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Intermittent Claudication Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Intermittent Claudication Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Intermittent Claudication Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Intermittent Claudication Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Intermittent Claudication Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Intermittent Claudication Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Intermittent Claudication Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Intermittent Claudication Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Intermittent Claudication Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Intermittent Claudication Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Intermittent Claudication Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Intermittent Claudication Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Intermittent Claudication Market Size by Country (2022-2027) & (US$ Million)
Table 61. I'ROM GROUP(DNAVEC Corporation) Company Details
Table 62. I'ROM GROUP(DNAVEC Corporation) Business Overview
Table 63. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Product
Table 64. I'ROM GROUP(DNAVEC Corporation) Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 65. I'ROM GROUP(DNAVEC Corporation) Recent Development
Table 66. Nuo Therapeutics Inc. Company Details
Table 67. Nuo Therapeutics Inc. Business Overview
Table 68. Nuo Therapeutics Inc. Intermittent Claudication Product
Table 69. Nuo Therapeutics Inc. Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 70. Nuo Therapeutics Inc. Recent Development
Table 71. Kowa Company Ltd. Company Details
Table 72. Kowa Company Ltd. Business Overview
Table 73. Kowa Company Ltd. Intermittent Claudication Product
Table 74. Kowa Company Ltd. Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 75. Kowa Company Ltd. Recent Development
Table 76. LTT Bio-Pharma Company Details
Table 77. LTT Bio-Pharma Business Overview
Table 78. LTT Bio-Pharma Intermittent Claudication Product
Table 79. LTT Bio-Pharma Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 80. LTT Bio-Pharma Recent Development
Table 81. Pluristem Therapeutics Inc. Company Details
Table 82. Pluristem Therapeutics Inc. Business Overview
Table 83. Pluristem Therapeutics Inc. Intermittent Claudication Product
Table 84. Pluristem Therapeutics Inc. Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 85. Pluristem Therapeutics Inc. Recent Development
Table 86. Nuo Therapeutics, Inc.(Aldagen, Inc.) Company Details
Table 87. Nuo Therapeutics, Inc.(Aldagen, Inc.) Business Overview
Table 88. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Product
Table 89. Nuo Therapeutics, Inc.(Aldagen, Inc.) Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 90. Nuo Therapeutics, Inc.(Aldagen, Inc.) Recent Development
Table 91. Genovate Biotechnology Co., Ltd. Company Details
Table 92. Genovate Biotechnology Co., Ltd. Business Overview
Table 93. Genovate Biotechnology Co., Ltd. Intermittent Claudication Product
Table 94. Genovate Biotechnology Co., Ltd. Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 95. Genovate Biotechnology Co., Ltd. Recent Development
Table 96. Novartis AG Company Details
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 99. Novartis AG Recent Development
Table 100. ID Pharma Co., Ltd Company Details
Table 101. ID Pharma Co., Ltd Business Overview
Table 102. ID Pharma Co., Ltd Intermittent Claudication Product
Table 103. ID Pharma Co., Ltd Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 104. ID Pharma Co., Ltd Recent Development
Table 105. Helixmith Co., Ltd. Company Details
Table 106. Helixmith Co., Ltd. Business Overview
Table 107. Helixmith Co., Ltd. Intermittent Claudication Product
Table 108. Helixmith Co., Ltd. Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 109. Helixmith Co., Ltd. Recent Development
Table 110. G. Pohl-Boskamp GmbH & Co. KG Company Details
Table 111. G. Pohl-Boskamp GmbH & Co. KG Business Overview
Table 112. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Product
Table 113. G. Pohl-Boskamp GmbH & Co. KG Revenue in Intermittent Claudication Business (2016-2021) & (US$ Million)
Table 114. G. Pohl-Boskamp GmbH & Co. KG Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intermittent Claudication Market Share by Type: 2020 VS 2027
Figure 2. Medication Therapies Features
Figure 3. Revascularization Features
Figure 4. Global Intermittent Claudication Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Home Healthcare Case Studies
Figure 8. Others Case Studies
Figure 9. Intermittent Claudication Report Years Considered
Figure 10. Global Intermittent Claudication Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Intermittent Claudication Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Intermittent Claudication Market Share by Regions: 2020 VS 2027
Figure 13. Global Intermittent Claudication Market Share by Regions (2022-2027)
Figure 14. Global Intermittent Claudication Market Share by Players in 2020
Figure 15. Global Top Intermittent Claudication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intermittent Claudication as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Intermittent Claudication Revenue in 2020
Figure 17. Global Intermittent Claudication Revenue Market Share by Type (2016-2021)
Figure 18. Global Intermittent Claudication Revenue Market Share by Type (2022-2027)
Figure 19. North America Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Intermittent Claudication Market Share by Type (2016-2027)
Figure 21. North America Intermittent Claudication Market Share by Application (2016-2027)
Figure 22. North America Intermittent Claudication Market Share by Country (2016-2027)
Figure 23. United States Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Intermittent Claudication Market Share by Type (2016-2027)
Figure 27. Europe Intermittent Claudication Market Share by Application (2016-2027)
Figure 28. Europe Intermittent Claudication Market Share by Country (2016-2027)
Figure 29. Germany Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Intermittent Claudication Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Intermittent Claudication Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Intermittent Claudication Market Share by Region (2016-2027)
Figure 39. China Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Intermittent Claudication Market Share by Type (2016-2027)
Figure 47. Latin America Intermittent Claudication Market Share by Application (2016-2027)
Figure 48. Latin America Intermittent Claudication Market Share by Country (2016-2027)
Figure 49. Mexico Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Intermittent Claudication Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Intermittent Claudication Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Intermittent Claudication Market Share by Country (2016-2027)
Figure 55. Turkey Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Intermittent Claudication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. I'ROM GROUP(DNAVEC Corporation) Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 59. Nuo Therapeutics Inc. Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 60. Kowa Company Ltd. Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 61. LTT Bio-Pharma Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 62. Pluristem Therapeutics Inc. Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 63. Nuo Therapeutics, Inc.(Aldagen, Inc.) Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 64. Genovate Biotechnology Co., Ltd. Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 65. Novartis AG Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 66. ID Pharma Co., Ltd Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 67. Helixmith Co., Ltd. Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 68. G. Pohl-Boskamp GmbH & Co. KG Revenue Growth Rate in Intermittent Claudication Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---